[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349293-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349293-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","dual-targeting-of-mitochondrial-metabolism-and-rho-gtpase-signaling-to-suppress-cancer-metastasis-review","Dual targeting of mitochondrial metabolism and Rho GTPase signaling to suppress cancer metastasis - Review","","Cancer metastasis remains largely incurable and a dominant driver of cancer-related deaths despite therapy advances. Metastatic dissemination relies on coordinated bioenergetic and mechanical adaptability governed by mitochondrial metabolism and Rho GTPase–controlled cytoskeletal dynamics. Mitochondria provide ATP and ROS that activate Rho signaling to promote invasion, while Rho-driven cytoskeletal remodeling repositions mitochondria to match local energy needs. This interdependence creates a therapeutic vulnerability that supports dual-targeting strategies combining Rho GTPase silencing with mitochondrial inhibition.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dual-targeting-of-mitochondrial-metabolism-and-rho-gtpase-signaling-to-suppress-cancer-metastasis-review/349293/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dual-targeting-of-mitochondrial-metabolism-and-rho-gtpase-signaling-to-suppress-cancer-metastasis-review/349293.png","ImageObject",300,407,{"name":42,"@type":43},"Grenda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is cancer metastasis difficult to treat, according to the review abstract?","Question",{"text":63,"@type":64},"Disseminated neoplastic disease remains largely incurable, and current therapies show limited efficacy against metastatic spread.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do mitochondrial metabolism and Rho GTPase signaling interact in promoting metastasis?",{"text":68,"@type":64},"Mitochondria generate ATP and ROS that activate Rho GTPase signaling, while Rho-driven cytoskeletal remodeling increases energy demand and drives mitochondrial redistribution, reinforcing metastatic progression.",{"name":70,"@type":61,"acceptedAnswer":71},"What dual-targeting strategy does the review discuss?",{"text":72,"@type":64},"It discusses combining Rho GTPase silencing (via small interfering RNA) with mitochondrial inhibition (via repurposed antibiotics) to disrupt both the cytoskeletal machinery and its metabolic support.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349293,1790220609,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","ONCOLOGY REPORTS 56: 143, 2026  \nDual targeting of mitochondrial metabolism and Rho GTPase signaling to suppress cancer metastasis (Review)  \nANGELINA DAHER 1* , ZAHRAAASSI 1* , AMJAD KANAAN2 , AHMAD AL KHATIB3 and MIRVAT EL SIBAI 1  \n1 2  \nDepartment of Biological Sciences, Lebanese American University, Beirut 1102 2801, Lebanon; Department of Biomedical Sciences, Faculty of Medicine and Medical Sciences, University of Balamand, Kalhat, P.O. Box 100 Tripoli, Lebanon;  \n3  \nDepartment of Internal Medicine and Gastroenterology, Hesse Clinic, Korbach Municipal Hospital, 34497 Korbach, Germany  \nReceived October 23, 2025; Accepted April 20, 2026  \nDOI: 10. 3892/or.2026.9148  \nAbstract. Despite the numerous advances in cancer therapy, disseminated neoplastic disease remains largely incurable and the primary cause of cancer‑related deaths. This process demands substantial bioenergetic and mechanical adaptability, orchestrated by two core cellular systems: Mitochondrial metabolism and Rho GTPase‑driven cytoskeletal dynamics. Traditionally studied independently, these systems form a tightly integrated, bidirectional network. Mitochondria supply ATP and reactive oxygen species (ROS) that fuel and signal through Rho GTPases to drive invasion, while cytoskeletal remodeling and cell polarity direct mitochondrial positioning to meet local energy demands. The present review synthesizesthe molecular mechanisms underlying this metabolic‑mechan‑ ical crosstalk and highlights a feedforward loop in which mitochondrial oxidative phosphorylation‑derived ATP and ROS activate Rho GTPase signaling, while Rho‑driven cyto‑ skeletal remodeling increases energy demand and promotes mitochondrial redistribution, thereby reinforcing metastatic progression. Critically, this interdependence represents a ther‑ apeutic vulnerability. A dual‑targeting strategy was discussed, combining Rho GTPase silencing (via small interfering RNA) with mitochondrial inhibition (via repurposed antibiotics) to simultaneously disrupt the cytoskeletal ‘engine’ and its metabolic ‘fuel’. Such approaches may overcome compensa‑ tory adaptive resistance that limits single‑target therapies . By framing mitochondrial and Rho GTPase signaling asan integrated functional axis, the present review provides a  \nCorrespondence to: Professor Mirvat El Sibai, Department of Biological Sciences, Lebanese American University, Chouran, Beirut 1102 2801, Lebanon  \nE‑[mail: mirvat.elsibai@lau.edu.lb](mail: mirvat.elsibai@lau.edu.lb)[ ](mail: mirvat.elsibai@lau.edu.lb)*Contributed equally  \nKey words: metastasis, Rho GTPases, mitochondrial metabolism, cytoskeletal dynamics, small interfering RNA therapeutics, dual‑targeting therapy, metabolic‑mechanical crosstalk, anti‑metastatic strategies  \nmechanistic and translational framework for the develop‑ ment of next‑generation, combination‑based anti‑metastatic therapies.  \nContents  \n1. Introduction  \n2. Mitochondrial metabolism and cancer metastasis  \n3. Rho GTPase signaling and siRNA in cancer metastasis  \n4. Crosstalk between mitochondria and Rho GTPases in cancer metastasis  \n5. Conclusion  \n1. Introduction  \nCancer is a leading cause of death worldwide, and metas‑ tasis accounts for most cancer‑related fatalities due to the limited efficacy of current therapies against disseminated disease (1‑3) . This multistep cascade, from local invasion to colonization, challenges cancer cells to overcome profound metabolic, mechanical and signaling stresses. While numerous oncogenic pathways contribute to dissemination, including Phosphoinositide 3‑kinase/Protein kinase B (PI3K/AKT), mitogen‑activated protein kinase (MAPK) signaling, and immune evasion mechanisms, the present review focuses on two core, interdependent systems that are fundamental to the metastatic process which are the cytoskeletal machinery and mitochondrial bioenergetics (4,5) .  \nA defining feature of metastatic cells is their capacity for dynamic cytoskeletal remodeling. This process is drive","cbCaiahRuwIPTPdX","https://ap.wps.com/l/cbCaiahRuwIPTPdX","pdf",3593673,21,"English","# Contents\n## Introduction\n## Mitochondrial metabolism and cancer metastasis\n## Rho GTPase signaling and siRNA in cancer metastasis\n## Crosstalk between mitochondria and Rho GTPases in cancer metastasis\n## Conclusion","[{\"question\":\"Why is cancer metastasis difficult to treat, according to the review abstract?\",\"answer\":\"Disseminated neoplastic disease remains largely incurable, and current therapies show limited efficacy against metastatic spread.\"},{\"question\":\"How do mitochondrial metabolism and Rho GTPase signaling interact in promoting metastasis?\",\"answer\":\"Mitochondria generate ATP and ROS that activate Rho GTPase signaling, while Rho-driven cytoskeletal remodeling increases energy demand and drives mitochondrial redistribution, reinforcing metastatic progression.\"},{\"question\":\"What dual-targeting strategy does the review discuss?\",\"answer\":\"It discusses combining Rho GTPase silencing (via small interfering RNA) with mitochondrial inhibition (via repurposed antibiotics) to disrupt both the cytoskeletal machinery and its metabolic support.\"}]","Dual targeting of mitochondrial metabolism and Rho GTPase signaling to suppress cancer metastasis - Review | PDF",1790082623,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46c66f758b44572611c57fc3f8ccff1d.webp",983,1357,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6ee05ef052f11b4ea60754f424e663d.webp",982,1356,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6bf8bb0a6571f8205ffb8a62c865b871.webp",981,1354,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/138b17fdde601445679743a5415fbc8f.webp",980,1353]